Alembic launches desonide creamAlembic’s desonide cream 0.05% is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatosis. Alembic intros generic TaxolPaclitaxel injection solution is indicated for several different types of cancer. Sandoz biologics license application for denosumab accepted by FDA Denosumab is indicated for treating variety of conditions, such as osteoporosis in postmenopausal women. Teva to pay Florida $6.73M to settle state’s price fixing claims Teva will pay Florida $6.73 million, and the state will dismiss all of its claims against the company and its affiliates once payment has been made. Lupin receives tentative nod from FDA for DETAF DETAF would be used for the management of HIV infections and will be available for low- and middle-income countries. Aurobindo receives FDA nod for generic Pennsaid Diclofenac sodium topical solution is indicated for the treatment of osteoarthritis. Alvotech, Advanz Pharma enter commercialization agreement for Xolair biosimilar Omalizumab is used to treat patients with allergic asthma, chronic spontaneous urticaria and nasal polyps. Upsher-Smith opens manufacturing facility in Minnesota Upsher-Smith is now offering contract manufacturing, packaging and serialization capabilities. Bajaj Medical debuts 2 generics Generic oral rinse (O.12% CHG) and generic lactulose solution 10g/15ml are being introduced into the marketplace. Mark Cuban Cost Plus Drug Company partners with OncoPower to provide cost savings to cancer patients The collaboration focuses on pricing transparency, affordable access and engaging cancer patients at home to ensure treatment adherence. First Previous 76 77 78 79 80 Next Last
